tradingkey.logo
tradingkey.logo
검색

Charles River Laboratories International Inc

CRL
관심 목록에 추가
234.300USD
-0.500-0.21%
종가 07-29 16:00ET시세는 15분 지연됩니다
11.29B시가총액
손실P/E TTM

Charles River Laboratories International Inc

234.300
-0.500-0.21%

자세한 내용은 Charles River Laboratories International Inc 회사

Charles River Laboratories International, Inc. is a drug development company. It provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes three businesses that provide foundational tools that enable its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.

Charles River Laboratories International Inc 정보

종목 코드 CRL
회사 이름Charles River Laboratories International Inc
상장일Jun 23, 2000
CEOFoster (James C)
직원 수18600
유형Ordinary Share
회계 연도 종료Jun 23
주소251 Ballardvale St
도시WILMINGTON
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가United States of America
우편 번호01887
전화17812226000
웹사이트https://www.criver.com/
종목 코드 CRL
상장일Jun 23, 2000
CEOFoster (James C)

Charles River Laboratories International Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Ms. Birgit Girshick
Ms. Birgit Girshick
Chief Operating Officer, Corporate Executive Vice President
Chief Operating Officer, Corporate Executive Vice President
58.79K
-5.76%
Mr. James C. Foster
Mr. James C. Foster
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
26.98K
-920.54%
Ms. Victoria L. (Vicky) Creamer
Ms. Victoria L. (Vicky) Creamer
Corporate Executive Vice President, Chief People Officer
Corporate Executive Vice President, Chief People Officer
20.94K
+19.00%
Mr. Joseph W. LaPlume
Mr. Joseph W. LaPlume
Corporate Executive Vice President - Corporate Development and Strategy
Corporate Executive Vice President - Corporate Development and Strategy
14.72K
+26.15%
Ms. Shannon M. Parisotto
Ms. Shannon M. Parisotto
Corporate Executive Vice President - Discovery and Safety Assessment Management
Corporate Executive Vice President - Discovery and Safety Assessment Management
10.72K
-14.26%
Ms. Virginia M. (Gina) Wilson, CPA
Ms. Virginia M. (Gina) Wilson, CPA
Independent Director
Independent Director
6.35K
+22.65%
Ms. Reshema Kemps-Polanco
Ms. Reshema Kemps-Polanco
Independent Director
Independent Director
4.56K
+43.24%
Dr. Craig B. Thompson, M.D.
Dr. Craig B. Thompson, M.D.
Independent Director
Independent Director
3.85K
+37.34%
Mr. Abraham N. (Abe) Ceesay
Mr. Abraham N. (Abe) Ceesay
Independent Director
Independent Director
2.38K
+60.32%
Mr. Paul W. Graves
Mr. Paul W. Graves
Independent Director
Independent Director
2.38K
+60.32%
더 보기
이름
이름/직위
직위
주식 보유
변동
Ms. Birgit Girshick
Ms. Birgit Girshick
Chief Operating Officer, Corporate Executive Vice President
Chief Operating Officer, Corporate Executive Vice President
58.79K
-5.76%
Mr. James C. Foster
Mr. James C. Foster
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
26.98K
-920.54%
Ms. Victoria L. (Vicky) Creamer
Ms. Victoria L. (Vicky) Creamer
Corporate Executive Vice President, Chief People Officer
Corporate Executive Vice President, Chief People Officer
20.94K
+19.00%
Mr. Joseph W. LaPlume
Mr. Joseph W. LaPlume
Corporate Executive Vice President - Corporate Development and Strategy
Corporate Executive Vice President - Corporate Development and Strategy
14.72K
+26.15%
Ms. Shannon M. Parisotto
Ms. Shannon M. Parisotto
Corporate Executive Vice President - Discovery and Safety Assessment Management
Corporate Executive Vice President - Discovery and Safety Assessment Management
10.72K
-14.26%
Ms. Virginia M. (Gina) Wilson, CPA
Ms. Virginia M. (Gina) Wilson, CPA
Independent Director
Independent Director
6.35K
+22.65%

자주 묻는 질문

Charles River Laboratories International Inc의 상위 5대 주주는 누구인가요?

Charles River Laboratories International Inc의 상위 5대 주주는 다음과 같습니다: Ms. Birgit Girshick

Charles River Laboratories International Inc(CRL)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Charles River Laboratories International Inc의 주식을 보유한 기관은 총 1429곳이며, 이들이 보유한 주식의 총 가치는 약 56.13M로 전체 발행 주식의 116.51%를 차지합니다. 이는 2025Q4 대비 -7963916.00 증가한 수치입니다.

Charles River Laboratories International Inc의 최대 수익원은 무엇인가요?

2026Q1 기준, Charles River Laboratories International Inc의 DSA 부문이 가장 높은 매출을 기록했으며, 금액은 2.40B로 전체 매출의 59.84%를 차지했습니다.
tradingkey.logo
위험 경고: 저희 웹사이트와 모바일 앱은 특정 투자 상품에 대한 일반적인 정보만을 제공합니다. Finsights는 재정적 조언이나 투자 상품에 대한 추천을 제공하지 않으며, 이러한 정보 제공이 Finsights가 금융 조언이나 추천을 제공하는 것으로 해석되어서는 안 됩니다.
투자 상품은 투자 원금 손실을 포함한 상당한 투자 위험에 노출되어 있으며, 모든 사람에게 적합하지 않을 수 있습니다. 투자 상품의 과거 성과는 미래 성과를 보장하지 않습니다.
Finsights는 제3자 광고주나 제휴사가 저희 웹사이트나 모바일 앱 또는 그 일부에 광고를 게재하거나 전달할 수 있도록 허용할 수 있으며, 사용자가 광고와 상호작용하는 방식에 따라 이들로부터 보상을 받을 수 있습니다.
© 저작권: FINSIGHTS MEDIA PTE. LTD. 모든 권리 보유